In addition, a variety of novel compounds have been designed and synthesized around the GPX4 target, such as ferrocene plus GPX4 inhibitors, which induce ferroptosis by modulating GPX4 activity, providing new strategies for cancer treatment [12,57,58,59,60,64,65]. Here, GPX4 is linked to cancer.